Justin D. Lauria-Banta

Associate

Justin D. Lauria-Banta

Associate

Justin Lauria-Banta focuses his representations on mergers and acquisitions, private equity, and equity financing for venture capital clients. Justin also regularly acts as outside general counsel for venture-backed companies. As a member of the firm’s Racial Justice and Equity Group, Justin also assists in the identification of potential engagements in matters involving unfair and unequal treatment based on race or ethnicity.

Before entering law school, Justin worked as a financial analyst with a Fortune 100 company.

Representative Experience

  • Represented Century Equity Partners in divestiture of Flores & Associates, LLC.
  • Represented Advocate Aurora Health in its strategic combination with Atrium Health to create the fifth-largest nonprofit health system in the country, with US$27bn in combined revenue and 67 hospitals located in six states.
  • Represented AXA Investment Managers in its investments in Eyenuk, Inc., Maternal Newborn Health Innovations, Inc., CXL Ophthalmics, Inc., and Ophirex, Inc.
  • Represented The Manitowoc Company, Inc. in its acquisition of Aspen Equipment Company.

Affiliations

  • Law Firm Antiracism Alliance

Presentations and Publications

  • Co-author, “AI and Carbon Credits: How the Emergence of AI Tools and Technologies Facilitates the Use of Carbon Credits,” Energy Current blog and Foley Insights (February 2023)
  • Co-author, “SEC Adopts New Rules Requiring Universal Proxy Cards in Contested Director Elections,” Foley Insights (December 2021)
  • Co-author, “Modernization of Management’s Discussion and Analysis and Other Financial Disclosures” Foley Insights (November 2020)
08 March 2024 Deals and Wins

Foley Represents Novacap in Strategic Partnership with INdigital

Foley & Lardner LLP served as legal advisor to Novacap, one of North America’s leading private equity firms, in its definitive agreement to acquire Communications Venture Corporation, Inc., doing business as INdigital.
03 August 2023 Deals and Wins

Foley Advises Bluestone Equity Partners in PMY Group Investment

Foley & Lardner LLP served as legal adviser to Bluestone Equity Partners, the global sports, media, and entertainment private equity firm, in its investment into PMY Group, a premier international venue, events, and infrastructure technology solutions firm.
10 February 2023 Innovative Technology Insights

AI and Carbon Credits: How the Emergence of AI Tools and Technologies Facilitates the Use of Carbon Credits

A carbon credit is a form of instrument or permit that represents one ton of carbon dioxide removed from the atmosphere.
18 October 2022 Deals and Wins

Foley Represents AXA IM Alts as Lead Investor in $26M Financing for Eyenuk

Foley & Lardner LLP represented AXA IM Alts, a global leader in alternative investments, as the lead investor in the $26 million Series A financing round for Eyenuk, Inc., a global artificial intelligence (AI) medical technology and services company and leader in real-world applications for AI Eye Screening and AI Predictive Biomarkers.
12 October 2022 Press Releases

Foley Represents AXA IM Alts as Lead Investor in $26M Financing Round for Maternal Newborn Health Innovations

Foley & Lardner LLP represented AXA IM Alts, a global leader in alternative investments with over $190 billion of assets under management, as the lead investor in the $26 million Series A financing round for Maternal Newborn Health Innovations (MNHI).
12 October 2022 Press Releases

Foley Represents AXA IM Alts as Lead Investor in $32M Series A Round in CXL Ophthalmics

Foley & Lardner LLP represented AXA IM Alts, a global leader in alternative investments, as the lead investor in the $32 million Series A funding round for CXL Ophthalmics, Inc. (CXLO), a clinical-stage company developing a minimally-invasive treatment for keratoconus.